Lumida
/CARE
⌘K
Carter Bankshares Inc

Carter Bankshares Inc

CARE
$31.23USD-1.17%-0.37 today

MARKET CAP

692.2M

P/E (TTM)

22.6x

FWD P/E

DAY RANGE

$31 – $32

52W RANGE

$17
$36

AI Summary

Stalk
StalkMedium

CARE holds a Stage 2 advancing structure with sharp parabolic acceleration, but price is extended well above the rising EMAs and showing extreme overbought signals. Short-term timing is unfavorable; wait for a pullback into or near the rising 20/50 EMA area for disciplined entry aligned with the medium-term bullish stage.

  • Resolved lawsuit reduces litigation risk, boosting share appeal
  • Earnings yield of 1.38 indicates solid return potential
  • Weak growth outlook signals stagnant revenue expansion
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$162.8M$181.9M$214.7M$243.1M$254.6M
YoY %-2.8%+11.7%+18.0%+13.2%+4.7%
P / Sales2.5x2.2x1.6x1.7x1.7x
EV / Sales23.7x23.3x20.7x18.7x18.7x
Gross Profit, Adj.$140.1M$161.6M$140.6M$135.8M$153.2M
YoY %+6.4%+15.4%-13.0%-3.4%+12.8%
Margin %86.0%88.9%65.5%55.9%60.2%
EV / Gross Profit27.5x26.2x31.7x33.5x31.1x
EBITDA, Adj.$39.3M$61.7M$28.7M$30.9M$40.0M
YoY %+129.9%+57.0%-53.5%+7.5%+29.6%
Margin %24.2%33.9%13.4%12.7%15.7%
EV / EBITDA98.0x68.6x155.0x147.2x119.2x
EBIT$35.7M$61.7M$28.7M$30.9M$40.0M
YoY %+179.2%+72.9%-53.5%+7.5%+29.6%
Margin %21.9%33.9%13.4%12.7%15.7%
EV / EBIT108.0x68.6x155.0x147.2x119.2x
Net Income$31.6M$50.1M$23.4M$24.5M$31.4M
YoY %+168.9%+58.7%-53.3%+4.9%+27.9%
Net Margin19.4%27.6%10.9%10.1%12.3%
EPS (GAAP)$1.19$2.03$1.00$1.06$1.38
YoY %+168.4%+70.6%-50.7%+6.0%+30.2%